
Researchers at Virginia Commonwealth University Massey Cancer Center have developed a new combination therapy that is providing promising results in overcoming the resistance of a substantial population of multiple myeloma patients towards treatment therapies. While several drugs are effective against multiple myeloma, including the proteasome inhibitor bortezomib, multiple myeloma cells are often able to survive by increasing the production of a protein known ...
Read More
You have just read an article categorized health
titled New Combination Therapy can Help Overcome Resistance to Therapies Among Multiple Myeloma Patients.
Written by:
editor -
Friday, May 2, 2014
There are currently no comments for "New Combination Therapy can Help Overcome Resistance to Therapies Among Multiple Myeloma Patients"
Post a Comment